Back to User profile » Dr Claudio Brescia
Paper published by Dr Claudio Brescia:
Short Report
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
Megna M, Ruggiero A, Tommasino N, Brescia C, Martora F, Cacciapuoti S, Potestio L
Clinical, Cosmetic and Investigational Dermatology 2024, 17:1037-1042
Published Date: 7 May 2024